Stocktoria
Kodiak Sciences Inc. KOD
Kodiak Sciences Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $182.4M | $126.1M | $206.3M | $267.6M | $217.3M | $107.4M | $37.5M | $18.8M | $22.0M |
| Operating income | -$234.4M | -$186.8M | -$277.3M | -$341.4M | -$267.1M | -$136.0M | -$49.2M | -$26.4M | -$25.5M |
| Interest expense | $0 | $0 | $13,000 | $18,000 | $47,000 | $25,000 | $8,000 | $5.5M | $1.2M |
| Income tax | $52,000 | $20,000 | $33,000 | $33,000 | $74,000 | $14,000 | — | — | — |
| Net income | -$230.0M | -$176.2M | -$260.5M | -$333.8M | -$267.0M | -$133.1M | -$47.4M | -$41.4M | -$27.9M |
| EPS (diluted) | $-4.32 | $-3.35 | $-4.97 | $-6.39 | $-5.16 | $-2.91 | — | — | — |
| Operating cash flow | -$136.0M | -$117.3M | -$154.2M | -$206.5M | -$182.3M | -$83.4M | -$39.1M | -$29.0M | -$17.7M |
| Free cash flow | -$136.5M | -$117.7M | -$195.5M | -$243.5M | -$199.3M | -$87.2M | -$39.6M | -$29.1M | -$17.9M |
| Cash & equivalents | $209.9M | $168.1M | $285.5M | $190.4M | $731.5M | $944.4M | $211.8M | $88.3M | $1.4M |
| Total assets | $351.5M | $335.6M | $479.4M | $666.6M | $904.2M | $1.1B | $358.9M | $92.2M | $3.2M |
| Total liabilities | $194.2M | $185.3M | $213.6M | $230.5M | $240.9M | $206.6M | $13.5M | $5.4M | $22.0M |
| Shareholders' equity | $157.4M | $150.3M | $265.8M | $436.2M | $663.3M | $860.8M | $345.4M | $86.8M | -$68.7M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.